Somatostatin receptor 4 ( SSTR4 ) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas
Molecular Oncology · 07.08.2026
DOI: 10.1002/1878-0261.70316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 07.08.2026. Verfasst von Ali Taqvi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical and Translational Research, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research Society SNGS, Canadian Institutes of Health Research Project Grant, Cancer Research Society.
Abstract (Originalsprache)
The mutational landscape of head & neck and cutaneous squamous cell carcinomas (HNSCC, cSCC) has major gene alterations involving PIK3CA , NOTCH1 , and TP53 among others that contribute to tumorigenesis. In this study, we focused on somatostatin receptor 4 ( SSTR4 ), which was identified in a recent in vivo HNSCC CRISPR screen. Mutations in the SSTR protein family are more commonly implicated in neuroendocrine tumors, and to date, no studies have shown a link between SSTR4 and cSCC/HNSCC. To understand the role of Sstr4 in skin keratinocytes, we employed transcriptomic profiling and proteomic methods and identified enriched pathways and protein–protein interactions (PPIs) networks. Sstr4 activation by J‐2156 agonist regulated MAPK‐ERK signaling pathway, which simultaneously limited G1 to S phase cell cycle progression. To validate Sstr4 as a driver of cSCC/HNSCC tumorigenesis, we performed a localized and clonal Sstr4 knockout in basal keratinocytes of the Pik3ca H1047R oncogenic mouse model using ultrasound‐guided in‐utero lentivirus injection technology. Tumor formation in mice following Sstr4 knockout occurred rapidly around 12 weeks. Our study is the first to uncover Sstr4 role in cSCC/HNSCC through in‐vivo models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical and Translational Research, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
- Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada.
- Department of Surgical and Interventional Sciences, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
- Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
- Department of Biochemistry, and Rosalind and Morris Goodman Cancer Research Institute, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
ORCID-Profile: Sampath Kumar Loganathan
Förderung
- Cancer Research Society SNGS
- Canadian Institutes of Health Research Project Grant
- Cancer Research Society
- Canadian Institutes of Health Research
Zitieren
APA
Taqvi, A., Huynh, T. K., Kadam, A., Kardan, Z., Yan, Y., Laham, A. J., & Loganathan, S. K. (2026). Somatostatin receptor 4 ( SSTR4 ) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas. Molecular Oncology. https://doi.org/10.1002/1878-0261.70316
Vancouver
Taqvi A, Huynh TK, Kadam A, Kardan Z, Yan Y, Laham AJ, et al. Somatostatin receptor 4 ( SSTR4 ) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas. Molecular Oncology. 2026. doi:10.1002/1878-0261.70316
BibTeX
@article{Taqvi2026,
author = {Taqvi, Ali and Huynh, Tuan Khang and Kadam, Adway and Kardan, Zahra and Yan, Yue and Laham, Amina Jamal and Loganathan, Sampath Kumar},
title = {Somatostatin receptor 4 ( SSTR4 ) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas},
journal = {Molecular Oncology},
year = {2026},
doi = {10.1002/1878-0261.70316}
}
EUVIMED